Get started
Author

Shriram D. Ranade

Observed names: Ranade, Shriram D., S. D. Ranade, Shriram Ranade
ORCID: 0000-0003-1575-1993
Observed ORCID: 0000-0003-1575-1993
OpenAlex ID: A5041317902
Indoles as promising Therapeutics: A review of recent drug discovery efforts
2024 · Naik Jui Pravin, Rohini S. Kavalapure, et al. · Bioorganic Chemistry · 70
Molecular hybridization, synthesis, in vitro α-glucosidase inhibition, in vivo antidiabetic activity and computational studies of isatin based compounds
2024 · Sunidhi Patil, Shankar G. Alegaon, et al. · Bioorganic Chemistry · 42
Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids
2024 · Shriram D. Ranade, Shankar G. Alegaon, et al. · Journal of Molecular Structure · 37
Design, synthesis of new 2,4-thiazolidinediones: In-silico, in-vivo anti-diabetic and anti-inflammatory evaluation
2024 · Shankar Gharge, Shankar G. Alegaon, et al. · European Journal of Medicinal Chemistry Reports · 36
Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study
2024 · Shriram D. Ranade, Shankar G. Alegaon, et al. · RSC Medicinal Chemistry · 35
PDF
Design, synthesis, characterization and antidiabetic evaluation of 3,5-substituted thiazolidinediones: Evidenced by network pharmacology, Molecular docking, dynamic simulation, in vitro and in vivo assessment
2024 · Shankar Gharge, Shankar G. Alegaon, et al. · European Journal of Medicinal Chemistry Reports · 31
Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant rats
2024 · Shriram D. Ranade, Shankar G. Alegaon, et al. · European Journal of Medicinal Chemistry · 30
Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents
2021 · Shankar G. Alegaon, Venkatasubramanian U, et al. · Journal of Biomolecular Structure and Dynamics · 30
Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents
2021 · Rohini S. Kavalapure, Shankar G. Alegaon, et al. · Bioorganic Chemistry · 29
Design, synthesis, molecular dynamics simulation, MM/GBSA studies and kinesin spindle protein inhibitory evaluation of some 4-aminoquinoline hybrids
2023 · Shriram D. Ranade, Shankar G. Alegaon, et al. · Computational Biology and Chemistry · 27
Sulfonamides: a versatile scaffold for diverse biological activity
2025 · Samiksha J. Kokre, Rohini S. Kavalapure, et al. · Results in Chemistry · 21
Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar rats
2024 · Shankar Gharge, Shankar G. Alegaon, et al. · Bioorganic Chemistry · 19
Novel rhodanine–thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach
2024 · Shankar Gharge, Shankar G. Alegaon, et al. · RSC Medicinal Chemistry · 18
PDF
Heterocyclic compounds with diverse biological activities: A review of quinazoline and quinazolinone derivatives
2025 · Aditi Kalakwade, Rohini S. Kavalapure, et al. · Results in Chemistry · 17
Design, synthesis and molecular dynamics simulations of thiazole-based hydrazones targeting MDA-MB-231 breast cancer cells
2025 · Shankar G. Alegaon, Shankar Gharge, et al. · Bioorganic Chemistry · 17
Computational and experimental repositioning of quinoline analogues as KSP inhibitors: insights from free energy landscape and PCA analysis
2025 · Shankar G. Alegaon, Shriram D. Ranade, et al. · Journal of Computer-Aided Molecular Design · 11
Structure-guided development of Quinoline derivatives targeting kinesin spindle protein
2025 · Rohini S. Kavalapure, Shankar G. Alegaon, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Synthesis and In vitro Biological Evaluation of Quinolone-Based Hydrazones as Potential Antidiabetic Agents Targeting Key Metabolic Enzymes
2025 · Naik Jui Pravin, Rohini S. Kavalapure, et al. · ACS Omega · 8
PDF
Thiazolidine Based Quinazoline Hybrids: Synthesis, Docking, DFT, Molecular Dynamic Study, and In Vitro Antidiabetic Evaluation
2025 · S. Gharge, S. G. Alegaon, et al. · Russian Journal of Bioorganic Chemistry · 8
Exploring the anti-obesity potential of Ailanthus excelsa Roxb in vitro enzymatic inhibition and computational pharmacology insights
2025 · Sachin Gudasi, M. B. Patil, et al. · Scientific Reports · 6
PDF
Novel quinoline–imidazole derivatives as inhibitors of Mycobacterium tuberculosis : an integrated approach combining molecular dynamics and in-vitro studies
2025 · Neha Khebude, Shankar G. Alegaon, et al. · Molecular Simulation · 6
Modulating glucose homeostasis via expression of PPAR-γ TF: Pharmacological insights into quinolone-based hydrazones
2025 · Naik Jui Pravin, Rohini S. Kavalapure, et al. · European Journal of Medicinal Chemistry · 5
Repositioning of rhodanine-thiazole hybrids as aldose reductase inhibitors
2025 · Shankar Gharge, Shankar G. Alegaon, et al. · Medicine in Drug Discovery · 5
New pyrimidine compounds as potent anti-breast cancer agents: synthesis, biological evaluation and computational studies
2026 · Niteen R. Sutar, Shankar G. Alegaon, et al. · Bioorganic Chemistry · 4
Comprehensive chemico-pharmacological profiling of Ailanthus excelsa Roxb bark: An integrated GC-MS/MS and molecular dynamics approach with free energy landscape and PCA insights
2026 · Sachin Gudasi, Shankar Gharge, et al. · Journal of Molecular Structure · 4
Works count: 50
Citation count: 545
H-index: 15
I10-index: 16
Year
Topic
Type